October 01, 2024 (MLN): Arif Habib Limited (PSX: AHL) announced today that the public subscription for BF Biosciences Limited will take place on October 2nd and 3rd, 2024.

Accordingly, investors can subscribe through Meezan Bank, HBL, Faysal Bank, or HabibMetro, or conveniently apply online via CDC & PSX’s e-IPO service.

The general public will subscribe to 6.25 million shares (25% of the total offer size) at a strike price of Rs77 per share.

This strike price reflects the upper limit of the 40% price band, determined through Book Building conducted on September 25 and 26, 2024.

The IPO received total participation of Rs4.67 billion against the issue size of Rs1.375bn on the floor price, an oversubscription of 3.4x.

BF Biosciences raised Rs1.93 billion in total, making it the first Pharma sector IPO in 2024. 

A total of 241 investors participated in the Book Building of BF Biosciences Limited, of which 185 investors were successful.

BFBL IPO: Putting Your Money Where the Growth Is

Copyright Mettis Link News

Posted on: 2024-10-01T13:25:08+05:00